Tandem secures FDA approval for Control-IQ+ use in pregnancy
Summary
Tandem has received FDA approval for its Control-IQ+ automated insulin delivery technology to be used during pregnancy in individuals with type 1 diabetes melli...
Description
Tandem has received FDA approval for its Control-IQ+ automated insulin delivery technology to be used during pregnancy in individuals with type 1 diabetes melli...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source